Stocks and InvestingStocks and Investing
Tue, April 9, 2019
Mon, April 8, 2019
Fri, April 5, 2019
Thu, April 4, 2019
Wed, April 3, 2019
Tue, April 2, 2019
Mon, April 1, 2019
Fri, March 29, 2019
Thu, March 28, 2019
Wed, March 27, 2019
Tue, March 26, 2019
Mon, March 25, 2019
Fri, March 22, 2019

Robyn Karnauskas Downgraded (BIIB) to Hold and Decreased Target to $230 on, Mar 22nd, 2019


Published on 2024-10-26 12:44:01 - WOPRAI, Robyn Karnauskas
  Print publication without navigation


Robyn Karnauskas of Citigroup, Downgraded "Biogen Inc." (BIIB) to Hold and Decreased Target from $470 to $230 on, Mar 22nd, 2019.

Robyn has made no other calls on BIIB in the last 4 months.



There are 6 other peers that have a rating on BIIB. Out of the 6 peers that are also analyzing BIIB, all agree with Robyn's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Alethia Young of "Cantor Fitzgerald" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
  • Matt Phipps of "William Blair" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
  • Steve Chesney of "Atlantic Equities" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
  • Ian Somaiya of "BMO Capital" Initiated at Hold and Held Target at $322 on, Friday, February 22nd, 2019
  • Adnan Butt of "Guggenheim" Downgraded from Strong Buy to Hold and Decreased Target to $325 on, Friday, February 22nd, 2019
  • Thomas Shrader of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $346 on, Thursday, February 21st, 2019